StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
JUSH

Jushi Holdings Inc.

JUSHF OTC Medicinal Chemicals & Botanical Products EDGAR ↗
$0.42
+0.01 +1.20%

Key statistics

from XBRL data in SEC filings
Market cap
Revenue (TTM)
Net income (TTM)
EPS (TTM)
P/E ratio
Dividend yield
Free cash flow
Cash
Total assets
Gross margin
52-week range
$0.35 – $0.98

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 28, 2026 8-K Results of operations (earnings release) Jul 28, 2026 8-K Shareholder vote results; Other events Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Other events Apr 24, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Results of operations (earnings release) Mar 31, 2026 8-K Director or officer change Jan 6, 2026 8-K Director or officer change Dec 16, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Sep 22, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Shareholder vote results; Regulation FD disclosure Jun 3, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 6, 2025 8-K Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Mar 3, 2025 8-K Unregistered sale of equity; Other events Feb 18, 2025 8-K Director or officer change Jan 8, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Took on a direct financial obligation; Director or officer change; Other events Sep 18, 2024 8-K Director or officer change Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Entered a material agreement; Terminated a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity Aug 6, 2024 8-K Shareholder vote results; Regulation FD disclosure Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Director or officer change Apr 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Regulation FD disclosure Mar 19, 2024 8-K Results of operations (earnings release) Mar 13, 2024 8-K Took on a direct financial obligation; Unregistered sale of equity Jan 30, 2024 8-K Took on a direct financial obligation; Unregistered sale of equity; Director or officer change Nov 16, 2023